Tech Company Financing Transactions
Biotia Funding Round
Biotia, based in New York, secured $2.4 million in investment from investiere and Hyperplane Venture Capital.
Transaction Overview
Company Name
Announced On
12/11/2019
Transaction Type
Venture Equity
Amount
$2,400,000
Round
Seed
Investors
investiere (Lead Investor)
Proceeds Purpose
The company intends to use the funds to further develop and implement its diagnostic testing methods, including its AI-based software Chelsea.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
100 6th Ave. 16th Floor
New York, NY 10013
USA
New York, NY 10013
USA
Phone
Undisclosed
Website
Email Address
Overview
Biotia is a health tech company launched from Jacobs Technion-Cornell Institute at Cornell Tech in association with Weill Cornell Medicine, located in New York, NY, that leverages DNA sequencing-based technology and proprietary AI-powered software to rapidly and accurately identify microorganisms and antimicrobial resistance.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Niamh O'Hara
Chief Medical Officer
Dorottya Nagy-Szakal
Chief Technical Officer
Rachid Ounit
Co-Founder
Christopher Mason
Browse more venture capital transactions:
Prev: 12/11/2019: Iterable venture capital transaction
Next: 12/11/2019: CyberGRX venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC investment data records on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs